Covid 19 Product Articles & Analysis
37 news found
In the face of global health crises such as the COVID-19 pandemic, the development and production of vaccines have become paramount to safeguarding public health and restoring normalcy. ...
The notable additions to Alfa Chemistry's IVD product portfolio are: COVID-19 Mutation RT-qPCR Detection Kit, COVID-19 RT-qPCR Detection Kit Plus, and COVID-19 RT-qPCR Detection Kit (RUO). COVID-19 Mutation RT-qPCR Detection Kit Alpha Delta Kappa ...
With an expert R&D team and a licenced manufacturing facility with a 50 million+ annual thin film capacity, the Firm is an ideal potential partner to produce XPhyto’s oral dissolvable (“ODF”) biosensor products. They are capable of thin film medical product formulation, mixing, coating, and packaging. In addition, the Firm has a portfolio of ...
XPhyto’s proprietary ODF biosensor development portfolio includes multiple oral health products, including for the detection of stomatitis, periodontitis, and periimplantitis. ...
according to the latest EU guidance MDCG 2021-21 Guidance on performance evaluation of SARS-CoV-2 in vitro diagnostic, which means this product gained official access to the EU market. The CE Certificate is quality proof that Reetoo’s COVID-19 self-test kit is well-qualified to be applied in the global market. Many countries have ...
The Virusight solution demonstrated an overall sensitivity of 92.7% (positive percent agreement) and specificity of 96.8% (negative percent agreement) as compared to an EC marked RT-PCR and was shown to be a safe and reliable test for the detection of SARS-CoV-2 antigens and/or virus particles in oral swab samples, providing diagnosis of active COVID-19, ...
Our commercial cartridge volumes continued to increase globally, with nearly 2,000 Idylla™ instruments installed, increasing product revenues to EUR 10.1m in Q1 2022. The growth was particularly strong in oncology with 42% higher cartridge revenue compared to Q1 2021, whereas the revenue contribution for COVID-19 testing expectedly reduced ...
This year we aim to launch our first ultra-rapid COVID-19 test products, followed by additional in-vitro diagnostic panels, including inflammation, triage, and hormone tests; as we begin to realize our vision of decentralizing diagnostic ...
“The review was delayed by one year due to COVID-19 priorities and now together with our partner Ascensia, we can execute our launch plan to deliver the Eversense E3 CGM System to U.S. patients beginning in the second quarter. ...
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the following statement from Douglas Bryant, Quidel’s President and CEO, regarding Quidel’s ongoing efforts to evaluate COVID-19 mutations and confirm that its antigen tests ...
Leblond and his team are using the new research infrastructure to create a saliva-based, reagent-free, rapid-screening test for COVID-19. This test uses Raman spectroscopy to analyze saliva in less than two minutes without the need for reagents such as enzymes, which all current chemical COVID-19 tests require. Reagents have ...
N1-methylpseudoUridine is an RNA modification that can be used to improve the safety and effectiveness of the COVID-19 messenger RNA vaccine. As a well-known supplier of pharmaceutical raw materials in the industry, BOC Sciences has been committed to producing COVID-19 mRNA vaccine raw materials with high quality. ...
Although most people think that covid-19 is not much different from the regular cold, the reality is the other way around. According to experts, covid-19 much more infections than the flu. 3. Pet animals can spread COVID-19 According to a report released by China, one of the dogs they tested for ...
ByOlansi
We are now looking at launching two branded products containing LEA™, which we currently expect will happen sometime between the first and second quarter of 2022,” said Dean Petkanas, CEO of Neuropathix. ...
miDiagnostics, a spin-off of the world-leading nano-electronics research center imec, today announced the launch of the holy grail for COVID-19 testing: an ultra-fast PCR test for point-of-care use. Flemish entrepreneurs-investors Marc Coucke, Urbain Vandeurzen and Michel Akkermans provide miDiagnostics with sufficient additional funding to support its ...
Smiths Detection, a global leader in threat detection and security screening technologies, confirms its BioFlash Biological Identifier is capable of detecting airborne COVID-19 following tests conducted by the University of Oregon, positioning the technology as an effective environmental monitoring tool for use in indoor public spaces. The University of Oregon ...
As part of the collaboration, Artificial will provide access to its aLab Suite software, designed to seamlessly integrate with Thermo Scientific Momentum Workflow software and robotics hardware. This will form part of the COVID-19 Testing Platform that will enable laboratories to quickly upscale COVID-19 testing volumes to help ...
Environmental Protection Agency (EPA) released much-anticipated draft guidance that will allow companies to demonstrate that their products have “long-lasting” or “residual” effectiveness on surfaces against viruses like SARS-CoV-2, the coronavirus that causes COVID-19. ...
iXensor, the pioneer of mobile health, today announced its “PixoTest® COVID -19 Antigen Self-Test Kit” has been granted by Taiwan FDA for EUA, in response to the recent peak of the epidemic and the new quarantine mandate of 0+7 taking effect on Oct 13th, Taiwan will officially enter the era of “self-initiated epidemic prevention”. ...
ByiXensor
Proceeds from any company or third-party sales of SHERLOCK CRISPR COVID-19 products will support racial and gender diversity in science, technology, engineering, and math—disciplines collectively known as STEM. ...